Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Ranee Mehra

Center AffiliationsMolecular Therapeutics

Publications (71) (print view)

no pagination
Rusthoven KE, Feigenberg SJ, Raben D, Kane M, Song JI, Nicolaou N, Mehra R, Burtness B, Ridge J, Swing R, Lango M, Cohen R, Jimeno A, Chen CH. INITIAL RESULTS OF A PHASE I DOSE-ESCALATION TRIAL OF CONCURRENT AND MAINTENANCE ERLOTINIB AND REIRRADIATION FOR RECURRENT AND NEW PRIMARY HEAD-AND-NECK CANCER. International Journal of Radiation Oncology Biology Physics. 2010 Nov;78(4):1020-5.   PMCID: not NIH funded
Tejani MA, Cohen RB, Mehra R. The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer. Biologics. 2010 Jan;4:173-85.   PMCID: PMC2921255
Turaka A, Li TY, Sharma NK, Li LN, Nicolaou N, Mehra R, Burtness B, Cohen RB, Lango MN, Horwitz EM, Ridge JA, Feigenberg SJ. Increased Recurrences Using Intensity-Modulated Radiation Therapy in the Postoperative Setting. American Journal of Clinical Oncology-Cancer Clinical Trials. 2010 Dec;33(6):599-603.   PMCID: not NIH funded
Borghaei H, Mehra R, Simon G. Current issues in adjuvant chemotherapy for resected, stage IB non-small-cell lung cancer. Future Oncol. 2009 Feb;5(1):19-22.   PMCID: Comment - no NIH
Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA. Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer. Annals of Oncology. 2009 Jul;20(7):1242-8.   PMCID: PMC2699385
Mehra R, Cohen RB. New agents in the treatment for malignancies of the salivary and thyroid glands. Hematol Oncol Clin North Am. 2008 Dec;22(6):1279-95, xi.   PMCID: PMC2659655
Mehra R, Cohen RB, Burtness BA. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck. Clinical advances in hematology & oncology : H&O. 2008 Oct;6(10):742-50.
Mehra R, Cohen RB, Harari P. Targeted therapies in head and neck cancer. In: Small W, editor. Combining targeted biological agents with radiotherapy : current status and future directions. New York: Demos Medical Pub.; 2008. p. 107-38.
Mehra R, Cohen RB, Harari PM. EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Current oncology reports. 2008 Mar;10(2):176-84.
Mehra R, Treat J. Part II: treatment of non-small-cell lung cancer: chemotherapy. In: Fishman AP, Elias JA, editors. Fishman's pulmonary diseases and disorders. New York: McGraw-Hill, Medical Pub. Division; 2008. p. 1867-82.
Mehra R, Burtness B. Antibody therapy for early-stage breast cancer: trastuzumab adjuvant and neoadjuvant trials. Expert Opin Biol Ther. 2006 Sep;6(9):951-62.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Ranee Mehra Sparkline Graph

Graph Interactions


Similar Investigators:

Keywords (MeSH):

Last updated on Wednesday, February 05, 2020